You have 9 free searches left this month | for more free features.

City

Salt Lake City (2)

Bronx (1)

Dallas (1)

Pittsburgh (1)

Portland (1)

Condition

Carcinoma of the Breast (1)

Malignant Melanoma (1)

Melanoma (1)

Refractory Head and Neck Cancer (1)

Squamous Cell Carcinoma, Skin (1)

Overall Status

Completed (1)

Terminated (1)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Takara Bio Inc. (1)

University of Utah (1)

Collaborator

Bristol-Myers Squibb (1)

Takara Bio Inc. (1)

Intervention

hf10 (2)

nivolumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

hf10

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Melanoma Trial in Salt Lake City (Nivolumab, HF10)

Terminated

Has Results

Melanoma

Nivolumab
HF10

Salt Lake City, Utah

Huntsman Cancer Institute

Jun 9, 2022

Refractory Head Neck Cancer, Squamous Cell Carcinoma, Skin, Carcinoma of the Breast Trial in United States (HF10)

Completed

Refractory Head and Neck Cancer
+3 more

HF10

Bronx, New York
+4 more

May 21, 2019